Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.
In: Thorax, Jg. 75 (2020-09-01), Heft 9, S. 808-811
academicJournal
Zugriff:
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) reportedly promotes, or conversely, resolves inflammation in asthma. In this study of TRAIL and cell receptors in sputum, bronchoalveolar lavage and biopsy from subjects in the Severe Asthma Research Program at Wake Forest, the high TRAIL group had significant increases in all leucocytes, and was associated with increased type 1, type 2 and type 17 cytokines, but not type 9 interleukin 9. Two variants at loci in the TRAIL gene were associated with higher sputum levels of TRAIL. Increased TRAIL decoy receptor R3/DcR1 was observed on sputum leucocytes compared with death receptor R1/DR4, suggesting reduced apoptosis and prolonged cellular inflammation. [ABSTRACT FROM AUTHOR]
Copyright of Thorax is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.
|
---|---|
Autor/in / Beteiligte Person: | Marks, Michelle ; Steele, Chad ; Moore, Wendy C. ; Meyers, Deborah A. ; Rector, Brian ; Ampleford, Elizabeth ; Bleecker, Eugene R. ; Hastie, Annette T. |
Zeitschrift: | Thorax, Jg. 75 (2020-09-01), Heft 9, S. 808-811 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0040-6376 (print) |
DOI: | 10.1136/thoraxjnl-2019-214496 |
Schlagwort: |
|
Sonstiges: |
|